Out of all analyzed candidate biomarkers, a panel which includes mediators of inflammation (IL-6, TNF-α) and mineral and bone disorder biomarkers (OPG, OPN, OCN, FGF-23, and Fetuin-A) was found to be more relevant than a single biomarker to detect patients in early CKD stages. Here, TNFRSF11B is linked to chronic kidney disease.